Clinical trials recruiting for Myasthenia Gravis (MG)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CD19/BCMA-targeted CAR-T cells | 1 |
| Cyclophosphamide | 1 |
| EVM18001 Injection | 1 |
| Fludarabine | 1 |
| HBI0101 CART | 1 |
| Lymphodepleting Conditioning | 1 |
| Universal CD19 CAR-γδT Cell Injection | 1 |
Self-screener
Recruiting trials
- CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
- Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
- Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
- Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Related conditions
Trials recruiting for Myasthenia Gravis (MG) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Myasthenia Gravis (MG) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.